Traveller vaccination tuberculosis: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Traveller vaccination | {{Traveller vaccination}} | ||
{{CMG}};{{AE}}{{USAMA}} | {{CMG}};{{AE}}{{USAMA}} | ||
==Overview== | ==Overview== |
Revision as of 18:15, 20 April 2017
Traveler Vaccination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Vaccination of young children against tuberculosis is not specific to the needs of travellers. In many countries BCG-vaccination of newborns and infants is routinely administered. Unvaccinated young children who are brought to an environment of high prevalence for tuberculosis should be offered vaccination according to the respective national recommendations.
Disease cause
The tubercle bacillus Mycobacterium tuberculosis.
Transmission
By inhalation of M. tuberculosis-containing microscopic droplets.
Nature of the disease
In most cases, exposure to M. tuberculosis results in latent infection, which only occasionally turns into active disease. Tuberculosis may affect any organ but, from a public health point of view, active pulmonary disease with mycobacterial dissemination is the most important manifestation. In infants, tuberculous meningitis or disseminated disease may occur. Multidrug-resistance of M. tuberculosis is a rapidly increasing problem.
Geographical distribution
Worldwide among deprived populations, but most common in poor countries. Tuberculosis is highly prevalent among HIV infected individuals.
Risk for travellers
Most travellers are at low risk for tuberculosis. On the other hand, for those coming from countries where its endemicity is low to work in, for example, emergency relief in countries highly endemic for tuberculosis the risk may be considerable. Individuals with HIV infection are particularly susceptible.
Vaccine
BCG vaccines are based on live attenuated mycobacterial strains descended from the original, attenuated bacillus CalmetteGuérin. Apart from its documented effect against tuberculous meningitis and disseminated disease in infants, BCG vaccination is of very limited value for most travellers.
Precautions
Where possible, travellers should avoid prolonged and close contact with people with known or suspected cases of pulmonary tuberculosis. A tuberculin skin test before and after a high-risk mission abroad may be advisable for example for health professionals and humanitarian relief workers.